Regeneron Pharmaceuticals, Inc. (REGN)
USD 581.68
(-4.74%)
USD 581.68
(-4.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.7 Billion USD | 0.06% |
| 2022 | 2.7 Billion USD | 0.06% |
| 2021 | 2.69 Billion USD | 0.15% |
| 2020 | 2.69 Billion USD | 277.6% |
| 2019 | 713.9 Million USD | 0.76% |
| 2018 | 708.5 Million USD | 0.72% |
| 2017 | 703.45 Million USD | 46.21% |
| 2016 | 481.12 Million USD | 28.13% |
| 2015 | 375.51 Million USD | -18.2% |
| 2014 | 459.06 Million USD | -9.19% |
| 2013 | 505.51 Million USD | 10.54% |
| 2012 | 457.32 Million USD | 5.0% |
| 2011 | 435.53 Million USD | 172.16% |
| 2010 | 160.03 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 5.09 Million USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 200 Million USD | 0.0% |
| 2005 | 200 Million USD | 0.0% |
| 2004 | 200 Million USD | 0.0% |
| 2003 | 200 Million USD | 0.0% |
| 2002 | 200 Million USD | -0.07% |
| 2001 | 200.15 Million USD | 9573.76% |
| 2000 | 2.06 Million USD | -23.37% |
| 1999 | 2.7 Million USD | -12.9% |
| 1998 | 3.1 Million USD | -18.42% |
| 1997 | 3.8 Million USD | -25.49% |
| 1996 | 5.1 Million USD | -15.0% |
| 1995 | 6 Million USD | -34.78% |
| 1994 | 9.2 Million USD | 55.93% |
| 1993 | 5.9 Million USD | 1.72% |
| 1992 | 5.8 Million USD | 141.67% |
| 1991 | 2.4 Million USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.98 Billion USD | 0.02% |
| 2024 Q1 | 1.98 Billion USD | 0.02% |
| 2024 Q3 | 2.7 Billion USD | 0.02% |
| 2023 Q1 | 2.7 Billion USD | 0.01% |
| 2023 Q4 | 2.7 Billion USD | 0.01% |
| 2023 FY | 2.7 Billion USD | 0.06% |
| 2023 Q2 | 2.7 Billion USD | 0.01% |
| 2023 Q3 | 2.7 Billion USD | 0.01% |
| 2022 Q2 | 1.98 Billion USD | -26.65% |
| 2022 Q3 | 2.7 Billion USD | 36.37% |
| 2022 FY | 2.7 Billion USD | 0.06% |
| 2022 Q1 | 2.7 Billion USD | 0.03% |
| 2022 Q4 | 2.7 Billion USD | 0.01% |
| 2021 FY | 2.69 Billion USD | 0.15% |
| 2021 Q2 | 1.97 Billion USD | 0.02% |
| 2021 Q1 | 1.97 Billion USD | -26.59% |
| 2021 Q3 | 1.97 Billion USD | 0.02% |
| 2021 Q4 | 2.69 Billion USD | 36.38% |
| 2020 Q2 | 715.9 Million USD | 0.1% |
| 2020 FY | 2.69 Billion USD | 277.6% |
| 2020 Q1 | 715.2 Million USD | 0.18% |
| 2020 Q4 | 2.69 Billion USD | 0.03% |
| 2020 Q3 | 2.69 Billion USD | 276.42% |
| 2019 FY | 713.9 Million USD | 0.76% |
| 2019 Q1 | 709.9 Million USD | 0.2% |
| 2019 Q2 | 711.3 Million USD | 0.2% |
| 2019 Q4 | 713.9 Million USD | 0.17% |
| 2019 Q3 | 712.7 Million USD | 0.2% |
| 2018 Q4 | 708.5 Million USD | 0.18% |
| 2018 FY | 708.5 Million USD | 0.72% |
| 2018 Q3 | 707.2 Million USD | 0.18% |
| 2018 Q2 | 705.9 Million USD | 0.18% |
| 2018 Q1 | 704.64 Million USD | 0.17% |
| 2017 FY | 703.45 Million USD | 46.21% |
| 2017 Q4 | 703.45 Million USD | 0.16% |
| 2017 Q1 | 700.4 Million USD | 45.58% |
| 2017 Q2 | 701.17 Million USD | 0.11% |
| 2017 Q3 | 702.31 Million USD | 0.16% |
| 2016 Q3 | 382.22 Million USD | 5.73% |
| 2016 Q4 | 481.12 Million USD | 25.87% |
| 2016 Q2 | 361.52 Million USD | -0.2% |
| 2016 Q1 | 362.23 Million USD | -3.54% |
| 2016 FY | 481.12 Million USD | 28.13% |
| 2015 Q4 | 375.51 Million USD | -4.9% |
| 2015 Q3 | 394.86 Million USD | 1.76% |
| 2015 Q1 | 472.47 Million USD | 2.92% |
| 2015 FY | 375.51 Million USD | -18.2% |
| 2015 Q2 | 388.04 Million USD | -17.87% |
| 2014 FY | 459.06 Million USD | -9.19% |
| 2014 Q1 | 530.05 Million USD | 4.85% |
| 2014 Q2 | 516.78 Million USD | -2.5% |
| 2014 Q3 | 564.06 Million USD | 9.15% |
| 2014 Q4 | 459.06 Million USD | -18.61% |
| 2013 Q4 | 505.51 Million USD | 5.01% |
| 2013 FY | 505.51 Million USD | 10.54% |
| 2013 Q1 | 461.27 Million USD | 0.86% |
| 2013 Q2 | 472.5 Million USD | 2.44% |
| 2013 Q3 | 481.38 Million USD | 1.88% |
| 2012 Q1 | 439.74 Million USD | 1.2% |
| 2012 Q2 | 445.04 Million USD | 1.21% |
| 2012 Q3 | 450.45 Million USD | 1.22% |
| 2012 FY | 457.32 Million USD | 5.0% |
| 2012 Q4 | 457.32 Million USD | 1.53% |
| 2011 Q2 | 159.45 Million USD | -0.43% |
| 2011 FY | 435.53 Million USD | 172.16% |
| 2011 Q4 | 434.52 Million USD | 172.46% |
| 2011 Q3 | 159.48 Million USD | 0.02% |
| 2011 Q1 | 160.15 Million USD | 0.08% |
| 2010 Q1 | 156.46 Million USD | 0.0% |
| 2010 FY | 160.03 Million USD | 0.0% |
| 2010 Q4 | 160.03 Million USD | 1.04% |
| 2010 Q3 | 158.38 Million USD | 0.65% |
| 2010 Q2 | 157.35 Million USD | 0.57% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q1 | - USD | -100.0% |
| 2009 Q2 | 62.92 Million USD | 0.0% |
| 2009 Q3 | 62.57 Million USD | -0.56% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | 5.09 Million USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | 5.09 Million USD | 0.0% |
| 2007 Q1 | 200 Million USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | 200 Million USD | 0.0% |
| 2007 Q2 | 200 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2006 Q1 | 200 Million USD | 0.0% |
| 2006 Q3 | 200 Million USD | 0.0% |
| 2006 FY | 200 Million USD | 0.0% |
| 2006 Q4 | 200 Million USD | 0.0% |
| 2006 Q2 | 200 Million USD | 0.0% |
| 2005 Q4 | 200 Million USD | 0.0% |
| 2005 Q3 | 200 Million USD | 0.0% |
| 2005 FY | 200 Million USD | 0.0% |
| 2005 Q2 | 200 Million USD | 0.0% |
| 2005 Q1 | 200 Million USD | 0.0% |
| 2004 Q3 | 200 Million USD | 0.0% |
| 2004 FY | 200 Million USD | 0.0% |
| 2004 Q4 | 200 Million USD | 0.0% |
| 2004 Q1 | 200 Million USD | 0.0% |
| 2004 Q2 | 200 Million USD | 0.0% |
| 2003 Q3 | 200 Million USD | -2.51% |
| 2003 Q2 | 205.14 Million USD | 2.57% |
| 2003 Q4 | 200 Million USD | 0.0% |
| 2003 FY | 200 Million USD | 0.0% |
| 2003 Q1 | 200 Million USD | 0.0% |
| 2002 Q1 | 200.05 Million USD | -0.05% |
| 2002 Q3 | 200 Million USD | 0.0% |
| 2002 Q2 | 200 Million USD | -0.03% |
| 2002 FY | 200 Million USD | -0.07% |
| 2002 Q4 | 200 Million USD | 0.0% |
| 2001 Q1 | 1.91 Million USD | -7.49% |
| 2001 Q4 | 200.15 Million USD | 12059.78% |
| 2001 Q3 | 1.64 Million USD | -5.89% |
| 2001 Q2 | 1.74 Million USD | -8.62% |
| 2001 FY | 200.15 Million USD | 9573.76% |
| 2000 FY | 2.06 Million USD | -23.37% |
| 2000 Q4 | 2.06 Million USD | -4.96% |
| 2000 Q3 | 2.17 Million USD | -6.81% |
| 2000 Q2 | 2.33 Million USD | -7.3% |
| 2000 Q1 | 2.52 Million USD | -6.67% |
| 1999 Q2 | 2.5 Million USD | -10.71% |
| 1999 FY | 2.7 Million USD | -12.9% |
| 1999 Q4 | 2.7 Million USD | 28.57% |
| 1999 Q3 | 2.1 Million USD | -16.0% |
| 1999 Q1 | 2.8 Million USD | -9.68% |
| 1998 Q4 | 3.1 Million USD | 14.81% |
| 1998 Q1 | 3.5 Million USD | -7.89% |
| 1998 Q2 | 3.6 Million USD | 2.86% |
| 1998 Q3 | 2.7 Million USD | -25.0% |
| 1998 FY | 3.1 Million USD | -18.42% |
| 1997 Q2 | 4.2 Million USD | -4.55% |
| 1997 Q3 | 4.1 Million USD | -2.38% |
| 1997 Q4 | 3.8 Million USD | -7.32% |
| 1997 Q1 | 4.4 Million USD | -13.73% |
| 1997 FY | 3.8 Million USD | -25.49% |
| 1996 Q2 | 4.9 Million USD | 0.0% |
| 1996 Q1 | 4.9 Million USD | -18.33% |
| 1996 FY | 5.1 Million USD | -15.0% |
| 1996 Q3 | 5.2 Million USD | 6.12% |
| 1996 Q4 | 5.1 Million USD | -1.92% |
| 1995 FY | 6 Million USD | -34.78% |
| 1995 Q1 | 8.6 Million USD | -6.52% |
| 1995 Q3 | 7 Million USD | -9.09% |
| 1995 Q2 | 7.7 Million USD | -10.47% |
| 1995 Q4 | 6 Million USD | -14.29% |
| 1994 FY | 9.2 Million USD | 55.93% |
| 1994 Q4 | 9.2 Million USD | 15.0% |
| 1994 Q2 | 7.2 Million USD | -11.11% |
| 1994 Q1 | 8.1 Million USD | 37.29% |
| 1994 Q3 | 8 Million USD | 11.11% |
| 1993 Q2 | 6.3 Million USD | 0.0% |
| 1993 Q4 | 5.9 Million USD | -4.84% |
| 1993 FY | 5.9 Million USD | 1.72% |
| 1993 Q3 | 6.2 Million USD | -1.59% |
| 1993 Q1 | 6.3 Million USD | 8.62% |
| 1992 Q2 | 4.8 Million USD | 17.07% |
| 1992 FY | 5.8 Million USD | 141.67% |
| 1992 Q4 | 5.8 Million USD | 11.54% |
| 1992 Q1 | 4.1 Million USD | 70.83% |
| 1992 Q3 | 5.2 Million USD | 8.33% |
| 1991 Q3 | 700 Thousand USD | 133.33% |
| 1991 Q2 | 300 Thousand USD | 0.0% |
| 1991 FY | 2.4 Million USD | 0.0% |
| 1991 Q4 | 2.4 Million USD | 242.86% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -3695.035% |
| Alkermes plc | 287.73 Million USD | -839.388% |
| Agenus Inc. | 137.32 Million USD | -1868.265% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | -15.359% |
| Aptorum Group Limited | 3.05 Million USD | -88273.386% |
| Ardelyx, Inc. | 51.54 Million USD | -5143.564% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -2483.837% |
| Bicycle Therapeutics plc | 40.08 Million USD | -6643.762% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -2586.833% |
| ChromaDex Corporation | 2.57 Million USD | -104866.99% |
| Chimerix, Inc. | 125 Thousand USD | -2162220.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -83358.103% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -10332.685% |
| CRISPR Therapeutics AG | 223 Million USD | -1112.025% |
| Precision BioSciences, Inc. | 7.72 Million USD | -34898.058% |
| Dyadic International, Inc. | 88.87 Thousand USD | -3041308.799% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -12285809.091% |
| Fortress Biotech, Inc. | 60.85 Million USD | -4341.468% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -4395145.219% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -71010.234% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -2998990.142% |
| Incyte Corporation | 29.16 Million USD | -9168.569% |
| IO Biotech, Inc. | 1.83 Million USD | -146876.618% |
| Jaguar Health, Inc. | 30.99 Million USD | -8621.002% |
| Novavax, Inc. | 168.01 Million USD | -1508.716% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -11638.979% |
| Opthea Limited | 200.53 Million USD | -1247.839% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -46866.116% |
| ContextLogic Inc. | 6 Million USD | -44948.333% |
| MiMedx Group, Inc. | 48.09 Million USD | -5519.452% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -13347.933% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -7058738.892% |
| NextCure, Inc. | 5.94 Million USD | -45334.527% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -1863968.966% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -12124.232% |
| PDS Biotechnology Corporation | 19.5 Million USD | -13756.632% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -2240.578% |
| Pharming Group N.V. | 166.1 Million USD | -1527.224% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -43403.943% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -7964.747% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -224021.061% |
| Acelyrin, Inc. | 1.19 Million USD | -226273.534% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -587486.957% |
| Summit Therapeutics Inc. | 103.29 Million USD | -2516.807% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -71613.982% |
| Senti Biosciences, Inc. | 33.53 Million USD | -7959.216% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -56528.955% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -7721.797% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -4380.861% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -172059.236% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -10539.663% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -2490.523% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -369148.634% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -24052.444% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -1854.318% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -20012.36% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -17919.333% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -1315.635% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -5032.933% |
| Fortress Biotech, Inc. | 60.85 Million USD | -4341.468% |
| Precigen, Inc. | 5.89 Million USD | -45750.721% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -6337.315% |
| AlloVir, Inc. | 16.64 Million USD | -16135.584% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -4010.437% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -2676.191% |
| ImmuCell Corporation | 10.54 Million USD | -25543.006% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -240157.778% |
| Onconetix, Inc. | 118.85 Thousand USD | -2273977.252% |
| PureTech Health plc | 18.25 Million USD | -14710.411% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -2730102.02% |
| Elevation Oncology, Inc. | 30.13 Million USD | -8868.71% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -10310.183% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -6204.287% |
| Innoviva, Inc. | 446.23 Million USD | -505.714% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -324377.791% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -4043494.04% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -1205.951% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -3696.421% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -84683.563% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -260294.99% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -12006.513% |
| Aptose Biosciences Inc. | 621 Thousand USD | -435149.597% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -267266.613% |
| Century Therapeutics, Inc. | 46.65 Million USD | -5693.004% |
| Kura Oncology, Inc. | 9.33 Million USD | -28863.781% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -10023.221% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -1958523.188% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -28700.213% |
| Autolus Therapeutics plc | 47.91 Million USD | -5541.149% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -54993.763% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -39806.984% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -1968.651% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -33248.55% |
| IGM Biosciences, Inc. | 34.67 Million USD | -7695.628% |
| INmune Bio, Inc. | 397 Thousand USD | -680731.234% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -1455.599% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -66568.147% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -1839245.623% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -5330.563% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -4853.088% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -5815.348% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -470.992% |
| Verastem, Inc. | 40.08 Million USD | -6642.753% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -61301.636% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -26783.827% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -41096.464% |
| Histogen Inc. | 4.38 Million USD | -61553.741% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -306351.247% |
| Organovo Holdings, Inc. | 888 Thousand USD | -304280.631% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -8909.667% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -64346.829% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -14204.843% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -3470.542% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -2902997.611% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -10333.088% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -1012222.097% |
| Amarin Corporation plc | 8.73 Million USD | -30836.248% |
| Mesoblast Limited | 100.48 Million USD | -2589.908% |
| Turnstone Biologics Corp. | 1.18 Million USD | -227225.484% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -3350.702% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -2479624.771% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -3195.858% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -1322.998% |
| Better Therapeutics, Inc. | 10.34 Million USD | -26020.023% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -11588.216% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -2805.313% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -209102.786% |
| Gritstone bio, Inc. | 40.14 Million USD | -6633.011% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -148902.205% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -1659.781% |
| Insmed Incorporated | 1.19 Billion USD | -126.496% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -42465.354% |
| OmniAb, Inc. | 22.07 Million USD | -12144.168% |
| Alector, Inc. | 30.45 Million USD | -8774.77% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -2561.802% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -33488.915% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -533.599% |
| Aura Biosciences, Inc. | 16.87 Million USD | -15921.932% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -4650.765% |
| Immunic, Inc. | 639 Thousand USD | -422889.045% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -8964.355% |
| Veracyte, Inc. | 7.52 Million USD | -35818.937% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -319.142% |
| FibroGen, Inc. | 89.69 Million USD | -2913.367% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -62221.881% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -2065342.486% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 47.085% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -7305035.135% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -136410.101% |
| TG Therapeutics, Inc. | 100.11 Million USD | -2599.714% |
| Galecto, Inc. | 66 Thousand USD | -4095203.03% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -1987326.471% |
| Fortrea Holdings Inc. | 1.63 Billion USD | -65.578% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -44835.993% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -49981.527% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -148902.205% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -12502.695% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -7294.064% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -522704.642% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -5875.108% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -8740.518% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -5932.99% |
| Vaxxinity, Inc. | 13.26 Million USD | -20280.787% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -233.171% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -601811.133% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -30653.214% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -855248.101% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -60530.328% |
| Ainos, Inc. | 5.92 Million USD | -45545.097% |
| Pluri Inc. | 29.05 Million USD | -9203.342% |
| Prothena Corporation plc | 10.72 Million USD | -25111.268% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -13515.939% |
| Celularity Inc. | 26.17 Million USD | -10225.477% |
| Rallybio Corporation | 173 Thousand USD | -1562269.942% |
| Cue Biopharma, Inc. | 4.2 Million USD | -64224.131% |
| MeiraGTx Holdings plc | 72.11 Million USD | -3647.833% |
| Omeros Corporation | 329.7 Million USD | -719.793% |
| Humacyte, Inc. | 38.6 Million USD | -6902.332% |
| Immunocore Holdings plc | 82.64 Million USD | -3170.534% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -167469.746% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -75463.321% |
| Blueprint Medicines Corporation | 610.96 Million USD | -342.401% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -185284.088% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -2739.509% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -5451.927% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -2873.455% |
| Pulmatrix, Inc. | 8.32 Million USD | -32359.469% |
| Elicio Therapeutics, Inc. | 6 Million USD | -44895.838% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -20779.876% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -2693.782% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -576211.301% |
| Cytokinetics, Incorporated | 607.37 Million USD | -345.015% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -30996.41% |
| Nutriband Inc. | 79.82 Thousand USD | -3385889.527% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -60178.769% |
| Vor Biopharma Inc. | 31.83 Million USD | -8391.675% |
| Roivant Sciences Ltd. | 477.85 Million USD | -465.631% |
| Evogene Ltd. | 10.65 Million USD | -25272.196% |
| ProKidney Corp. | 3.61 Million USD | -74772.576% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -356013.307% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -10266936.39% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | -55.723% |
| CorMedix Inc. | 517.01 Thousand USD | -522691.497% |
| BioLineRx Ltd. | 6.62 Million USD | -40680.024% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -7237.26% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -3667.581% |
| Atai Life Sciences N.V. | 15.21 Million USD | -17669.377% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -320761.265% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -1059860.784% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -6163.963% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -658084.386% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -197336.085% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -407516.359% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -1417.886% |
| Biomea Fusion, Inc. | 7.83 Million USD | -34419.796% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -851.012% |
| Mereo BioPharma Group plc | 5.3 Million USD | -50898.113% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -125616.279% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -459576.871% |
| Absci Corporation | 4.66 Million USD | -57902.146% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -23358.601% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -11809.672% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -26915.492% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -23393.264% |
| Allakos Inc. | 38.21 Million USD | -6972.877% |
| Imunon, Inc. | 1.13 Million USD | -237143.624% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -31223.444% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -323213.397% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -27028900.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -2959.448% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -57298.598% |
| XOMA Corporation | 118.51 Million USD | -2180.582% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -26743.778% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -7189.571% |
| aTyr Pharma, Inc. | 13.76 Million USD | -19533.181% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -34118.255% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -10727.191% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -13277.382% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -18019233.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -971502.142% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -18598.904% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | -80.284% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1984801.559% |
| UroGen Pharma Ltd. | 98.55 Million USD | -2642.641% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -1712.64% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -14075.801% |
| Entera Bio Ltd. | 256 Thousand USD | -1055720.313% |
| GH Research PLC | 631 Thousand USD | -428251.823% |
| Lisata Therapeutics, Inc. | 137.00 USD | -1972919608.029% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -420912.461% |
| Xencor, Inc. | 14.64 Million USD | -18359.91% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -1798823.135% |
| Replimune Group, Inc. | 71.99 Million USD | -3654.549% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -1801833.333% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -38479.789% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1984801.559% |
| Portage Biotech Inc. | 7000.00 USD | -38612757.143% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -407516.359% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -189046.256% |
| OncoCyte Corporation | 2.2 Million USD | -122536.116% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -4039807.331% |
| Purple Biotech Ltd. | 163 Thousand USD | -1658120.859% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -106523.274% |
| scPharmaceuticals Inc. | 38.81 Million USD | -6864.263% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -10607.099% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -3702502.74% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -145766.163% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -10158.464% |
| Curis, Inc. | 1.48 Million USD | -181424.513% |
| Daré Bioscience, Inc. | 3.91 Million USD | -68962.947% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -387293.133% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -45048233.333% |
| BeiGene, Ltd. | 197.61 Million USD | -1267.74% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -296433.187% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -3254.514% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -5109.004% |
| bluebird bio, Inc. | 224.41 Million USD | -1104.399% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -355.728% |
| DBV Technologies S.A. | 4.52 Million USD | -59619.399% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -201608.955% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -27644.816% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -71652.057% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -616.45% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -6203.846% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -157319.918% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -291160.776% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -15374.323% |
| MacroGenics, Inc. | 30.19 Million USD | -8851.186% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -15168.034% |
| Prime Medicine, Inc. | 4.35 Million USD | -61935.804% |
| Aditxt, Inc. | 1.04 Million USD | -259359.138% |
| Adagene Inc. | 13.54 Million USD | -19862.284% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -19576.057% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -421.084% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -15712.906% |
| SciSparc Ltd. | 24 Thousand USD | -11261983.333% |
| Vericel Corporation | 81.85 Million USD | -3202.018% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -3195.543% |
| Generation Bio Co. | 89.77 Million USD | -2910.783% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -12083.457% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -1239.402% |
| Invivyd, Inc. | 722 Thousand USD | -374262.881% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -5472.76% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -92446876.978% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -70564.052% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -11751639.13% |
| 2seventy bio, Inc. | 244.01 Million USD | -1007.687% |
| ADMA Biologics, Inc. | 130.59 Million USD | -1969.697% |
| Clene Inc. | 7.15 Million USD | -37692.226% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -79956.062% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -991.565% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -245395.005% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -1028146.438% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -1303.229% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -9416.248% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -27941.291% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -2320.37% |
| Evaxion Biotech A/S | 8.48 Million USD | -31740.97% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -3507.474% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -4076.621% |
| Trevena, Inc. | 35.23 Million USD | -7571.501% |
| Surrozen, Inc. | 882 Thousand USD | -306351.247% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -43382.947% |
| Cingulate Inc. | 135.09 Thousand USD | -2000580.982% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -11382.646% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -5554.603% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -1501511.111% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -10550.144% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -15400.946% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -288671.368% |
| Statera Biopharma, Inc. | 11.43 Million USD | -23545.061% |
| ImmunityBio, Inc. | 836.95 Million USD | -222.946% |
| Korro Bio, Inc. | 31.21 Million USD | -8558.701% |
| Kineta, Inc. | 150 Thousand USD | -1801833.333% |
| BioVie Inc. | 349.89 Thousand USD | -772391.097% |
| Codexis, Inc. | 12.24 Million USD | -21977.105% |
| Celularity Inc. | 26.17 Million USD | -10225.477% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -5583.735% |
| Celcuity Inc. | 37.03 Million USD | -7198.15% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -1532634.129% |
| Cibus, Inc. | 17.67 Million USD | -15193.086% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -79891.122% |
| Kodiak Sciences Inc. | 100 Million USD | -2602.9% |
| Annexon, Inc. | 29.19 Million USD | -9159.678% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -4082.308% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -240800.178% |
| Avalo Therapeutics, Inc. | 2 Million USD | -135045.0% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | -93.012% |
| Eyenovia, Inc. | 8.95 Million USD | -30075.62% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -4016.572% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -33097.003% |
| Arcellx, Inc. | 50.84 Million USD | -5216.379% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -185284.088% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -12626.716% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -256099.052% |
| Moolec Science SA | 99.04 Thousand USD | -2728834.031% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -9685.67% |
| Geron Corporation | 35.05 Million USD | -7611.335% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -457243.486% |
| Royalty Pharma plc | 6.13 Billion USD | 55.945% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -164510.231% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -8515116.432% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -11576.603% |
| Humacyte, Inc. | 38.6 Million USD | -6902.332% |
| Structure Therapeutics Inc. | 4.01 Million USD | -67253.601% |
| 89bio, Inc. | 24.79 Million USD | -10800.988% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -21637.977% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -144749.946% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -261808.915% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -2616.264% |
| Notable Labs, Ltd. | 1.52 Million USD | -177023.198% |
| Liquidia Corporation | 2.36 Million USD | -114235.871% |
| Mustang Bio, Inc. | 1.97 Million USD | -136548.129% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -19576.057% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -38773.867% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -852549.842% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -5319.131% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -28043.482% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -4127158.013% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -1987326.471% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -43049.745% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -2079053.846% |
| PepGen Inc. | 17.1 Million USD | -15706.433% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -570132.068% |
| United Therapeutics Corporation | 300 Million USD | -800.967% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -11189.838% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -64829.044% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -467529.758% |
| XOMA Corporation | 118.51 Million USD | -2180.582% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -7305035.135% |
| Bionomics Limited | 117.62 Million USD | -2197.837% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -289599.893% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -48080.036% |
| uniQure N.V. | 130.06 Million USD | -1978.115% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -4513.245% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -393908.746% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -62221.881% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -195055.235% |
| Altimmune, Inc. | 175 Thousand USD | -1544414.286% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -596.879% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -48080.036% |
| Compugen Ltd. | 719 Thousand USD | -375824.896% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -53253.731% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -3096.618% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -27119.537% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -42271.845% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -2856.897% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -27119.537% |
| Instil Bio, Inc. | 81.42 Million USD | -3219.415% |
| argenx SE | 15.35 Million USD | -17503.882% |
| Immunome, Inc. | 1.34 Million USD | -201608.955% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -504172.388% |
| Verona Pharma plc | 48.37 Million USD | -5487.506% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -29228.342% |
| Shattuck Labs, Inc. | 3.4 Million USD | -79257.017% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -3179782.353% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -1608769.048% |
| Moolec Science SA | 99.04 Thousand USD | -2728834.031% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -24400.397% |
| AnaptysBio, Inc. | 16.03 Million USD | -16754.15% |
| Design Therapeutics, Inc. | 2.33 Million USD | -115705.484% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -9984385.243% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -44948.333% |
| Achilles Therapeutics plc | 1.07 Million USD | -251098.885% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -29228.342% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -13557785.233% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -16044.011% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -3385889.527% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -36226947.313% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -20791438.462% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -689.209% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -10939.454% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -108016.432% |
| Palisade Bio, Inc. | 90 Thousand USD | -3003122.222% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -1393147.423% |
| Beam Therapeutics Inc. | 159.91 Million USD | -1590.253% |
| Neurogene Inc. | 13.37 Million USD | -20111.62% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -782.087% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -10191.665% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -4518137.438% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -270190.0% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -6572.509% |
| Athira Pharma, Inc. | 1.21 Million USD | -221995.316% |
| Vaccinex, Inc. | 26 Thousand USD | -10395669.231% |
| HCW Biologics Inc. | 6.3 Million USD | -42773.789% |
| XOMA Corporation | 118.51 Million USD | -2180.582% |
| Nektar Therapeutics | 112.62 Million USD | -2299.911% |
| Arvinas, Inc. | 800 Thousand USD | -337762.5% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -18598.904% |
| Merus N.V. | 10.48 Million USD | -25671.358% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -18058.549% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -20027.336% |
| Rezolute, Inc. | 1.66 Million USD | -162725.301% |
| Clene Inc. | 7.15 Million USD | -37692.226% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -3684935.72% |
| BeyondSpring Inc. | 3.36 Million USD | -80247.8% |
| Synlogic, Inc. | 12.49 Million USD | -21538.78% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -8176.886% |
| Krystal Biotech, Inc. | 6.62 Million USD | -40729.305% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -1481.392% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -44978.386% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -5705711.572% |
| MannKind Corporation | 252.15 Million USD | -971.937% |
| Ikena Oncology, Inc. | 7.18 Million USD | -37544.847% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -1358141.206% |
| Gossamer Bio, Inc. | 197.4 Million USD | -1269.216% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -519688.462% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -860.765% |
| Mural Oncology plc | 8.91 Million USD | -30232.174% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -6080.035% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -188124.234% |
| Champions Oncology, Inc. | 6.09 Million USD | -44260.742% |
| REGENXBIO Inc. | 82.22 Million USD | -3187.32% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -547042.426% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -60858.502% |
| Vaxart, Inc. | 2.62 Million USD | -102946.13% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -994963.156% |
| Cellectis S.A. | 36.24 Million USD | -7358.128% |
| Longeveron Inc. | 1.44 Million USD | -186564.365% |
| Repare Therapeutics Inc. | 1.01 Million USD | -267513.861% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | -138.664% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -5937.437% |
| Revolution Medicines, Inc. | 80.57 Million USD | -3254.514% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -84154.988% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -1526962.147% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -2197379.675% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -272.968% |
| Denali Therapeutics Inc. | 44.98 Million USD | -5908.982% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -21515.851% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -2000580.982% |
| Passage Bio, Inc. | 22.92 Million USD | -11692.243% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -44657.41% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -417658.887% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -13303.918% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -551512.245% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -663258.342% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -227416.835% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -579921.459% |
| OmniAb, Inc. | 22.07 Million USD | -12144.168% |
| Anew Medical, Inc. | 1.54 Million USD | -175412.987% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -9043.78% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -29822.506% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -8593.792% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -66568.147% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -5142.547% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -42351.704% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -19030.158% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -402117.262% |
| Alumis Inc. Common Stock | 30.86 Million USD | -8658.587% |
| Equillium, Inc. | 384 Thousand USD | -703780.208% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -43785.371% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -1689.419% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -5429.778% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -2246662.315% |
| Dominari Holdings Inc. | 3.02 Million USD | -89163.54% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -13669550.534% |
| vTv Therapeutics Inc. | 169 Thousand USD | -1599249.112% |
| Bio-Techne Corporation | 319 Million USD | -747.304% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -4642.928% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -1413.67% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -17443.324% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -21727.505% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -56128.417% |
| Nkarta, Inc. | 82.27 Million USD | -3185.402% |
| BioCardia, Inc. | 982 Thousand USD | -275144.399% |
| Iterum Therapeutics plc | 18.95 Million USD | -14158.81% |